Treatment of Schizoaffective Disorder Using Mifepristone

Not Recruiting

Trial ID: NCT00725270

Purpose

This study tests the hypothesis that mifepristone will diminish cognitive distortion and alleviate psychosis in patients with schizoaffective disorder.

Official Title

Treatment of Schizoaffective Disorder Using Mifepristone

Stanford Investigator(s)

Hugh Brent Solvason PhD MD
Hugh Brent Solvason PhD MD

Clinical Professor, Psychiatry and Behavioral Sciences

Jennifer Keller
Jennifer Keller

Clinical Professor, Psychiatry and Behavioral Sciences

Eligibility


Inclusion Criteria:The subjects will be 30 inpatients or outpatients with schizoaffective
disorder. Exclusion Criteria:Subjects must be between the ages of eighteen and seventy-five
without major medical problems.

Intervention(s):

drug: Mifepristone

drug: Placebo Oral Tablet

drug: Placebo Oral Tablet

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jessica Hawkins
6507238323